Forsythoside A attenuates metabolic dysfunction in type 2 diabetic mice by inhibiting the MAPK and activating the Nrf2 signalling pathways
By: Mengxian Shu and Chunhui Xiang
Language: English, Croatian, Slovenian
Page range: 21 - 27
Submitted on: Jul 1, 2025
Accepted on: Mar 1, 2026
Published on: Mar 30, 2026
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Mengxian Shu, Chunhui Xiang, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution 4.0 License.